AMINOSYN Drug Patent Profile

Which patents cover Aminosyn, and when can generic versions of Aminosyn launch?

Aminosyn is a drug marketed by Icu Medical Inc, Abbott, Otsuka Icu Medcl, Hospira, and Hospira Inc. and is included in thirty NDAs.

The generic ingredient in AMINOSYN is amino acids; dextrose; magnesium chloride; potassium acetate; potassium chloride; potassium phosphate, dibasic; sodium chloride. There are three hundred and fifty drug master file entries for this compound. Additional details are available on the amino acids; dextrose; magnesium chloride; potassium acetate; potassium chloride; potassium phosphate, dibasic; sodium chloride profile page.

Summary for AMINOSYN

US Patents:	0
Applicants:	5
NDAs:	30
Drug Prices:	Drug price information for AMINOSYN
DailyMed Link:	AMINOSYN at DailyMed

See drug prices for AMINOSYN

US Patents and Regulatory Information for AMINOSYN

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Otsuka Icu Medcl	AMINOSYN-PF 7%	amino acids	INJECTABLE;INJECTION	019398-001	Sep 6, 1985		RX	No	No
Abbott	AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINER	amino acids; dextrose	INJECTABLE;INJECTION	019713-001	Sep 9, 1988		DISCN	No	No
Abbott	AMINOSYN II 3.5% IN PLASTIC CONTAINER	amino acids	INJECTABLE;INJECTION	019491-001	Oct 10, 1986		DISCN	No	No
Hospira Inc	AMINOSYN II 4.25% M IN DEXTROSE 10% IN PLASTIC CONTAINER	amino acids; dextrose; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic, heptahydrate	INJECTABLE;INJECTION	019682-002	Nov 1, 1988		DISCN	No	No